Description

Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-2,2,2-Trifluoro-n-(2-Furanylmethyl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure incorporating quinoline and furan moieties. This compound is of significant value in medicinal chemistry research and development, particularly for its role as a key building block in the synthesis of novel therapeutic agents. It is primarily sought by R&D laboratories and pharmaceutical manufacturers engaged in the development of targeted small-molecule drugs, where precise chemical structure and purity are paramount for successful clinical outcomes.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, especially in oncology and antiviral research.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Active Pharmaceutical Ingredient (API) Development: Employed in the development and scale-up processes for new chemical entities (NCEs) targeting specific disease pathways.
• Biochemical Tool Compound: Utilized in vitro and in vivo to study biological mechanisms and validate novel therapeutic targets.
• Contract Research & Manufacturing (CRMO): Supplied to service organizations supporting pharmaceutical companies with custom synthesis and process development.
• Academic Research: Used in university and institutional labs for cutting-edge research in organic synthesis and drug discovery projects.

Basic Information

Item	Details
Product Name	Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-2,2,2-Trifluoro-n-(2-Furanylmethyl)- (9Ci)
CAS No.	606103-01-9
Molecular Formula	C19H16ClF3N2O3
Molecular Weight	412.79 g/mol
Synonyms	N-[(2-Chloro-6-methoxyquinolin-3-yl)methyl]-2,2,2-trifluoro-N-(furan-2-ylmethyl)acetamide; 2,2,2-Trifluoro-N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]-N-2-furanylmethyl-Acetamide; Acetamide, N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]-2,2,2-trifluoro-N-(2-furanylmethyl)-; 606103-01-9; UNII-8V8P1549QN
EINECS	Contact for details

Quality Control

Our Acetamide, n-[(2-Chloro-6-Methoxy-3-Quinolinyl)Methyl]-2,2,2-Trifluoro-n-(2-Furanylmethyl)- (9Ci) is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. Comprehensive Certificates of Analysis (COA) detailing purity, impurities, and full spectroscopic data (NMR, MS) are provided to guarantee traceability and support your regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound is moisture-sensitive (hygroscopic); therefore, the container must be kept tightly sealed under an inert atmosphere to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Unknown Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.